In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure

被引:29
作者
Akahoshi, T [1 ]
Kobayashi, N [1 ]
Hosaka, S [1 ]
Sekiyama, N [1 ]
Wada, C [1 ]
Kondo, H [1 ]
机构
[1] KITASATO UNIV, SCH MED, DEPT CLIN PATHOL, SAGAMIHARA, KANAGAWA 228, JAPAN
关键词
chronic renal failure; haemodialysis; monocyte chemotactic and activating factor;
D O I
10.1093/ndt/10.12.2244
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Monocyte chemotactic and activating factor (MCAF) is a novel inflammatory cytokine belonging to the chemokine superfamily and stimulates chemotaxis and activation of monocytes. Increased production of inflammatory cytokines has been shown in patients with end-stage renal disease (ESRD). This study was thus conducted to determine plasma MCAF in patients with ESRD. Methods. Plasma levels of MCAF were determined by ELISA. Gene expression of MCAF in PBMC was assessed by RT-PCR followed by southern blot hybridization. Results. Plasma MCAF in 72 patients with long-term haemodialysis (HD) (162.4 +/- 58.2 pg/ml) and eight uraemic patients not yet dialysed (167.6 +/- 57.7 pg/ml) was found to exceed significantly the level in 24 normal subjects (86.0 +/- 19.4 pg/ml). MCAF before HD session in long-term HD patients was the same whether HD was carried out with either cellulosic (CUP) or synthetic (PMMA) membrane dialysers. Intradialytic increase in plasma MCAF during a single HD session was observed in both patient groups dialysed with CUP or PMMA membranes. The results of RT-PCR analysis indicated that haemodialysis stimulates the gene expression of MCAF in PBMC in vivo. Conclusions. The present results indicate that increased levels of plasma MCAF may promote the activation of monocytes in patients with ESRD.
引用
收藏
页码:2244 / 2249
页数:6
相关论文
共 19 条
[1]   EXPRESSION OF MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR IN RHEUMATOID-ARTHRITIS - REGULATION OF ITS PRODUCTION IN SYNOVIAL-CELLS BY INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR [J].
AKAHOSHI, T ;
WADA, C ;
ENDO, H ;
HIROTA, K ;
HOSAKA, S ;
TAKAGISHI, K ;
KONDO, H ;
KASHIWAZAKI, S ;
MATSUSHIMA, K .
ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :762-771
[2]   PLASMA INTERLEUKIN-1 ACTIVITY DURING HEMODIALYSIS - THE INFLUENCE OF DIALYSIS MEMBRANES [J].
BINGEL, M ;
LONNEMANN, G ;
KOCH, KM ;
DINARELLO, CA ;
SHALDON, S .
NEPHRON, 1988, 50 (04) :273-276
[3]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138
[4]  
DESCAMPSLATSCHA B, 1993, KIDNEY INT, V43, pS135
[5]   CLONING AND SEQUENCING OF THE CDNA FOR HUMAN MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR (MCAF) [J].
FURUTANI, Y ;
NOMURA, H ;
NOTAKE, M ;
OYAMADA, Y ;
FUKUI, T ;
YAMADA, M ;
LARSEN, CG ;
OPPENHEIM, JJ ;
MATSUSHIMA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (01) :249-255
[6]  
GUSSOW D, 1987, J IMMUNOL, V139, P3132
[7]   INVIVO INDUCTION OF INTERLEUKIN-1 DURING HEMODIALYSIS [J].
HAEFFNERCAVAILLON, N ;
CAVAILLON, JM ;
CIANCIONI, C ;
BACLE, F ;
DELONS, S ;
KAZATCHKINE, MD .
KIDNEY INTERNATIONAL, 1989, 35 (05) :1212-1218
[8]   ELEVATED CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
HERBELIN, A ;
URENA, P ;
NGUYEN, AT ;
ZINGRAFF, J ;
DESCAMPSLATSCHA, B .
KIDNEY INTERNATIONAL, 1991, 39 (05) :954-960
[9]   INFLUENCE OF UREMIA AND HEMODIALYSIS ON CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA [J].
HERBELIN, A ;
NGUYEN, AT ;
ZINGRAFF, J ;
URENA, P ;
DESCAMPSLATSCHA, B .
KIDNEY INTERNATIONAL, 1990, 37 (01) :116-125
[10]   DETECTION OF MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR (MCAF) IN NORMAL BLOOD AND URINE USING A SENSITIVE ELISA [J].
IDA, N ;
SAKURAI, S ;
KAWANO, G .
CYTOKINE, 1994, 6 (01) :32-39